Disease Progression on Lorlatinib or Osimertinib What Happens When Tagrisso Stops Working
In discussion with Dr. Stephen Liu, covering the World Conference on Lung Cancer Highlights from Community Oncology Osimertinib resistance in non-small cell lung cancer: Pathways and potential solutions Elaine Shum, MD, an assistant professor in the Department of Medicine at NYU Grossman School of Medicine, discusses Case 4: Treating EGFR+ NSCLC After Osimertinib ...